{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:56:25Z","timestamp":1793048185959,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.clim.2013.06.007","type":"journal-article","created":{"date-parts":[[2013,7,6]],"date-time":"2013-07-06T16:02:20Z","timestamp":1373126540000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset"],"prefix":"10.1016","volume":"149","author":[{"given":"David C.","family":"Soler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica V.","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2013.06.007_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0010","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.clim.2013.06.007_bb0015","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2013.06.007_bb0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2013.06.007_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2013.06.007_bb0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/502980","article-title":"CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells","volume":"193","author":"Campanelli","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2013.06.007_bb0035","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2004-07-2505","article-title":"CCR6 expression defines regulatory effector\/memory-like cells within the CD25(+)CD4+ T-cell subset","volume":"105","author":"Kleinewietfeld","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.06.007_bb0040","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1002\/1521-4141(200212)32:12<3506::AID-IMMU3506>3.0.CO;2-#","article-title":"Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1\/I-309","volume":"32","author":"Colantonio","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0045","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2353\/ajpath.2010.090759","article-title":"CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells","volume":"176","author":"Dobaczewski","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2013.06.007_bb0050","doi-asserted-by":"crossref","first-page":"H1418","DOI":"10.1152\/ajpheart.01002.2010","article-title":"CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction","volume":"300","author":"Zamilpa","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.clim.2013.06.007_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.micinf.2008.11.012","article-title":"Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1\/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage","volume":"11","author":"Medeiros","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.clim.2013.06.007_bb0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/427515","article-title":"CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi","volume":"191","author":"Machado","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2013.06.007_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0016-5085(03)00903-X","article-title":"CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells","volume":"125","author":"Luangsay","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2013.06.007_bb0070","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coi.2009.09.011","article-title":"Regulatory T cells and inhibitory cytokines in autoimmunity","volume":"21","author":"Bettini","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.0105-2896.2005.00247.x","article-title":"Regulatory T cells and autoimmune disease","volume":"204","author":"Paust","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2013.06.007_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.smim.2008.01.001","article-title":"The central role of the Th17 lineage in regulating the inflammatory\/autoimmune axis","volume":"19","author":"Weaver","year":"2007","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.clim.2013.06.007_bb0100","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0105","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.1001455","article-title":"Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression","volume":"186","author":"Goodman","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.1200266","article-title":"The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector\/memory regulatory T cells","volume":"189","author":"Chang","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1747.1998.00419.x","article-title":"Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets","volume":"111","author":"Szabo","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2013.06.007_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000131424","article-title":"Psoriasis","volume":"10","author":"Nestle","year":"2008","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.clim.2013.06.007_bb0125","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.4049\/jimmunol.177.4.2039","article-title":"CCR5 in T cell-mediated liver diseases: what's going on?","volume":"177","author":"Ajuebor","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.06.007_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbamem.2003.09.006","article-title":"Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages","volume":"1617","author":"Slimani","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2013.06.007_bb0135","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1084\/jem.20060956","article-title":"CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence","volume":"203","author":"Yurchenko","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2013.06.007_bb0140","first-page":"1628","article-title":"CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Bogunia-Kubik","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.clim.2013.06.007_bb0145","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood-2005-04-1632","article-title":"Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease","volume":"106","author":"Wysocki","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.06.007_bb0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00403-007-0764-7","article-title":"Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor","volume":"299","author":"de Groot","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2013.06.007_bb0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1684\/ejd.2012.1730","article-title":"Reduction of RANTES expression in lesional psoriatic skin after narrow band ultraviolet therapy: a possible marker of therapeutic efficacy","volume":"22","author":"Rateb","year":"2012","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.clim.2013.06.007_bb0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/jid.2012.333","article-title":"mTORC2-PKBalpha\/Akt1 Serine 473 phosphorylation axis is essential for regulation of FOXP3 Stability by chemokine CCL3 in psoriasis","volume":"133","author":"Chen","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2013.06.007_bb0165","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/jid.2011.127","article-title":"CCL4L polymorphisms and CCL4\/CCL4L serum levels are associated with psoriasis severity","volume":"131","author":"Pedrosa","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2013.06.007_bb0170","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2012","journal-title":"J. Invest. Dermatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661613001861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661613001861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T23:04:29Z","timestamp":1688339069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661613001861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1521661613001861"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2013.06.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2013.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}